SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-024966
Filing Date
2021-05-06
Accepted
2021-05-06 16:10:30
Documents
3
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oric-8k_20210506.htm 8-K 37276
2 EX-99.1 oric-ex991_6.htm EX-99.1 158729
3 GRAPHIC gev1z1eqfjrw000001.jpg GRAPHIC 1896
  Complete submission text file 0001564590-21-024966.txt   199930
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39269 | Film No.: 21897831
SIC: 2834 Pharmaceutical Preparations